Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5224_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
02.09.2026
Размер:
21 Мб
Скачать
86 C. Lauwers et al.
Table 8.1 Suggested mechanisms explaining lack of benet of early full nutrition in RCTs
Suggested mechanism Supporting evidence?
Without supportive evidence
Inclusion of too many patients con­sidered at low nutritional risk
Unfavorable energy to protein dose No.
Absence of indirect calorimetry­guided energy dosing
With supportive evidence
Anabolic resistance Yes.
Suppression of autophagy Yes.
Suppression of ketogenesis Yes.
RCT randomized controlled trial
No. No subgroup differences in RCTs. No validated biomarker that can identify patients beneting from early full nutritional support
No benet and potential harm by high-dose proteins in RCTs.
No. No benet of indirect calorimetry- vs. calculation-based energy dosing in RCTs. Endogenous energy suppression (not quantied) cannot be fully suppressed by articial nutrition.
No prevention of muscle wasting by in RCTs. Increased ureagenesis by increased amino acid doses, suggesting futile catabolism of provided amino acids.
Suppression of autophagy in muscle of patients receiving early full nutrition, associating with more muscle weak­ness. Suppression of autophagy in muscle and vital organs of critically ill animals receiving early full nutrition, asso­ciating with muscle degeneration and poor organ function.
Suppression of part explaining harm by early full nutrition. Exogenous ketone supplements protected critically ill animals against muscle weakness.
ketogenesis in
early full
critically ill patients, in
nutrition
total study population, supporting dose-dependent harm by early nutritional support
3]. Also, in a secondary analysis of the PermiT RCT that extensively studied
[ potential nutritional risk markers, no marker could identify patients who beneted from early full nutritional support [28]. Whether novel nutritional risk markers may discriminate which patients would benet from early full feeding requires further study [29]. However, in the absence of new evidence, one should be cautious.
Unfavorable Energy to Protein Doses
Experts have advocated that patients in recent feeding RCTs may have received too low amino acid doses, and too high glucose and lipid doses [
22]. However, RCTs
8 The Energy Intake: How Much, and at What Time? 87
that specically studied protein supplements in critically ill patients have not shown benet by increased protein doses, and even suggested potential harm. Indeed, in the EFFORT RCT (N = 1329), high-dose protein (target 2.2 g/kg/d; prescribed
1.6 ± 0.5 g/kg/d) did not improve outcome as compared with standard care (target
1.2 g/kg/d; prescribed 0.9 ± 0.3 g/kg/d) in mechanically ventilated critically ill patients [ failure scores, high-dose protein even associated with harm [ Nephro-Protective RCT (N = 474), amino acid supplements up to maximum 2 g/ kg/d did not improve outcome, with a trend toward increased use of renal replace­ment therapy [31]. These RCT data do not support early high-dose protein in critical illness. These ndings are corroborated by secondary analyses of the EPaNIC and PEPaNIC RCTs that attributed harm by early parenteral nutrition to the increased amino acid dose rather than to increased glucose or lipid doses [
30]. In patients with acute kidney injury and in patients with high organ
30]. A
lso, in the
13, 14].
Absence of Indirect Calorimetry-Guided Energy Dosing
Recent large feeding RCTs have been criticized for the use of predictive equations to guide energy dosing [25]. Numerous observational studies have shown that predic­tive equations only give an imprecise estimation of energy expenditure, as measured by indirect calorimetry [25]. However, large RCTs have not shown clear benetof indirect calorimetry-based energy dosing as compared with calculation-based energy dosing [32, 33]. Moreover, equaling measured energy expenditure with the energy target builds on the assumption that all endogenous energy substrate production can be counteracted by providing nutrients [26]. Especially in the acute phase of critical illness, this assumption is not valid, however, and the time when endogenous substrate production is fully suppressible by feeding remains unclear, as outlined below. Moreover, the largest RCT studying indirect calorimetry-based versus calculation-based energy dosing, the TICACOS-International RCT (N = 417) may question the feasibility of routine use of indirect calorimetry, since the RCT was stopped prematurely because of insufcient patient recruitment after 6 years in 7 expert centers [33, 34]. Moreover, of 417 patients in the intention-to-treat popu­lation, indirect calorimetry-based feeding was performed in only 332 patients [33].
Anabolic Resistance
The primary aim of providing nutrition is to avoid critical illness-associated catab­olism, which leads to muscle wasting and weakness and is associated with poor outcomes. However, acute critical illness is characterized by anabolic resistance [35], as also conrmed by recent RCTs [13, 36]. Muscle proteolysis, which provides substrate for hepatic gluconeogenesis, seems mainly driven by the endocrine and inammatory alterations accompanying acute critical illnesses [
26].
RCTs have
88 C. Lauwers et al.
shown that these processes cannot be counte racted by providing early full nutritional support [13, 36]. Indeed, providing higher doses of amino acids in the acute phase of illness through early parenteral nutrition or amino acid supplements uniformly increased urea concentrations in critically ill patients, suggesting that a large fraction of the extra amino acids is not incorporated into protein but degraded [14, 30, 31,
37–39]. In the EPaNIC RCT, it was estimated that almost two thirds of the extra
provided amino acids through early parenteral nutrition were net wasted into ureagenesis [ cally important, as it statistically explained the increased need for renal replacement therapy [37]. Concomitantly, there was no prevention of microscopic or macro­scopic muscle loss, and muscle weakness was even more prevalent in patients receiving early parenteral nutrition, which may be explained by suppression of muscle repair pathways, as outlined below [13, 36]. Importantly, early indirect calorimetry-based feedingas discussed abovedoes not consider endogenous substrate production that is not always suppressible by exogenous nutrients
40]. Hence, indirect calorimetry-based feeding may lead to overfeeding if measured
[ energy expenditure is set as the energy target [26]. Since the extent of insuppressible endogenous energy production cannot be quantied, indirect calorimetry-based feeding may theoretically introduce itsown methodological inaccuracy, just like calculated energy dosing, especially in acutely ill patients. Also, the time point when anabolic resistance turns into feeding responsiveness, with suppressible muscle catabolism and gluconeogenesis, indicating feeding readiness cannot be predicted or monitor based feeding may be valuable in the recovery phase of critical illness, allowing to avoid overfeeding and underfeeding. However, RCTs studying the impact of indirect calorimetry-based feeding initiated after the rst week in ICU and extended into the recovery phase are lacking.
37]. Feeding-induced increased ureagenesis may have been clini-
ed, and likely varies between patients [26]. In theory, indirect calorimetry-
Suppression of Fasting-Induced Recovery Pathways
Apart from anabolic resistance, the lack of benet from early feeding may be explained by the suppression of fasting-induced benets [26]. Indeed, although fasting has been regarded as a negative phenomenon in critical illness, recent evidence suggests that the fasting response may be adaptive to some extent. Prolonged fasting powerfully activates autophagy and ketogenesis, which may enhance recovery from a critical insult [41]. Autophagy is a housekeeping process that removes damaged organelles, intracellular microorganisms, and potentially toxic protein aggregates, among others [42, 43]. The process is powerfully inhibited by providing macronutrients, and mechanistic studies have shown that active autophagy is essential to recover from critical insults [44]. Mechanistic studies have shown that early parenteral nutrition-induced autophagy suppression was asso­ciated with poor muscle and organ function in critically ill patients and animals [36, 45]. Likewise, fasting activates the generation of ketones, which may stimulate
8 The Energy Intake: How Much, and at What Time? 89
autophagy and have been implicated in muscle regeneration pathways [41]. Mecha­nistic studies have shown that the protective effects of withholding early parenteral nutrition may partly be explained by increased ketogenesis [46, 47]. Moreover, exogenous administration of ketones protected critically ill mice against muscle weakness [48].

Future Perspectives

Exploiting Fasting-Induced Benets While Avoiding Prolonged Starvation
Although the fasting response has been associated with the activation of benecial repair pathways in critical illness, prolonged starvation will likely come at the price of devastating sarcopenia and muscle weakness. Therefore, current guidelines rec­ommend to administer full feeding from the second week in the ICU at the latest [49]. However, also in patients with prolonged critical illness and persistent organ failure, repair pathways, including autophagy, are likely important. Yet, the efcacy and safety of macronutrient restriction beyond the rst week in ICU have not been studied, and continued starvation for weeks is obviously unwanted. Future studies should investigate whether alternative feeding strategies could activate fasting responses while avoiding prolonged starvation and whether this is clinically supe­rior. In this regard, fasting responses have also been implicated in protection against age-related disease [50]. In this context, the benecial effects of caloric restriction have been replicated by so-called fasting-mimicking diets [50]. In critical illness, candidate alternative feeding strategies are intermittent fasting, ketogenic diets, or ketone supplementation [ mount a fasting response and associated benets in critically ill patients remains unclear. A pilot crossover RCT (N = 70) showed that 12 h of fasting induced a metabolic fasting response with increased ketogenesis in prolonged critically ill patients, although autophagy activation in white blood cells was unaf­fected [51]. Whether continued application of intermittent fasting intervals would translate into a clinical benet remains unclear. RCTs comparing intermittent versus continuous feeding have shown mixed results [52, 53]. However, most RCTs were relatively small, and the fasting interval in these studies (generally only 4 to 6 h) may have been too short to impact the outcome benecially [41].
41]. However, the ideal duration of fasting that is needed to
Development and Validation of Tools to Guide Individualized Nutritional Support
Future studies should investigate whether nutritional support, preferably guided by markers of nutritional need and feeding responsiveness, improves outcome. In contrast to RCTs in ICU patients, an RCT in hospitalized non-critically ill patients
90 C. Lauwers et al.
showed that enhanced nutritional support improved outcome [54]. Yet, translation of these results into the ICU setting is difcult, as most patients were able to receive oral feeding in this study. As anabolic resistance and the need for active repair processes are presumably dynamic over time and variable between patients, there is a need for validated biomarkers or prediction tools that can predict and monitor feeding responsiveness, and detect under- and overfeeding before overt symptoms
28, 5
occur, which needs further study [ there may be a role of indirect calorimetry to guide energy dosing, which also needs further study. Likewise, the ideal ratio of carbohydrate versus lipid calories remains to be studied in large RCTs.
5]. In patients who are feeding-responsive,

Implications for Clinical Practice

In the absence of a biomarker or monitor that can adequately predict or document the response to articial nutrition, it remains unclear how to optimally titrate nutritional intake in individual patients over time. Although early enhanced articial feeding did not benet critically ill patients, prolonged underfeeding likely comes at a price. In patients unable to eat, it seems reasonable to start with low-dose enteral nutrition within 48 h, as recommended by European guidelines [ increased gradually up to target, or low-dose trophic enteral nutrition can be con­sidered in the rst week. In case of enteral feeding intolerance or a contraindication to enteral nutrition, parenteral nutrition should be withheld, and low intake should be tolerated up to 1 week after ICU admission [49]. Throughout ICU stay, sufcient micronutrient intake should be ensured, which may imply parenteral administration in case of no or only minimal enteral intake [49]. Especially in patients with prolonged low intake before ICU admission and in patients with other risk factors of deciencies, early parenteral administration of vitamins and trace elements should be considered [56]. Since commercial enteral nutrition formulae contain micronutrients, parenteral vitamins and trace elements can usually be stopped when the feeding target is almost reached by enteral or oral nutrition. When a patient develops refeeding hypophosphatemia, it seems prudent to temporarily restrict macronutrient intake, while correcting micronutrient and electrolyte deciencies, to prevent potentially lethal complications of refeeding syndrome [17, 18]. there
is no benet of using measured energy targets in the rst week of critical illness, the potential role of indirect calorimetry in prolonged critically ill patients and in patients recovering from critical illness remains unclear.
49]. Enteral nutrition can be
While

Conclusion

Recent large RCTs have shown that early full nutritional support to critically ill patients induced dose-dependent harm, regardless of the feeding route. Currently, no validated nutritional risk scores or biomarkers identify patients who benet from
8 The Energy Intake: How Much, and at What Time? 91
early enhanced nutritional support. The absence of benet of early full nutritional support has been attributed to anabolic resistance and suppression of fasting-induced recovery pathways, including autophagy and ketogenesis. This opens perspectives for intermittent feeding/fasting strategies, ketone supplementation, and ketogenic diets. The time point when anabolic resistance switches into feeding responsiveness is likely variable, cannot be monitored
or predicted, and requires further study. In the absence of such a monitor, the value of indirect calorimetry remains obscure, especially in the acute phase of critical illness.

References

1. Dvir D, Cohen J, Singer P. Computerized energy balance and complications in critically ill patients: an observational study. Clin Nutr. 2006;25(1):37–44.
2. Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, et al. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an interna­tional multicenter observational study. Intensive Care Med. 2009;35(10):1728–37.
3. Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365(6):506–17.
4. Fivez T, Kerklaan D, Mesotten D, Verbruggen S, Wouters PJ, Vanhorebeek I, et al. Early versus late parenteral nutrition in critically ill children. N Engl J Med. 2016;374(12):1111–22.
5. Reignier J, Plantefeve G, Mira J-P, Argaud L, Asfar P, Aissaoui N, et al. Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3). Lancet Respir Med. 2023;11(7): 602–12.
6. Verstraete S, Verbruggen SC, Hordijk JA, Vanhorebeek I, Dulfer K, Güiza F, et al. Long-term developmental effects of withholding parenteral nutrition for 1 week in the paediatric intensive care unit: a 2-year follow-up of the PEPaNIC international, randomised, controlled trial. Lancet Respir Med. 2019;7(2):141–53.
7. Jacobs A, Dulfer K, Eveleens RD, Hordijk J, Van Cleemput H, Verlinden I, et al. Long-term developmental effect of withholding parenteral nutrition in paediatric intensive care units: a 4-year follow-up of the PEPaNIC randomised controlled trial. Lancet Child Adolesc Health. 2020;4(7):503–14.
8. Rice TW, Wheeler AP, Thompson BT, Steingrub J, Hite RD, Moss M, et al. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA. 2012;307(8):795–803.
9. Arabi YM, Aldawood AS, Haddad SH, Al-Dorzi HM, Tamim HM, Jones G, et al. Permissive underfeeding or standard enteral feeding in critically ill adults. N Engl J Med. 2015;372(25): 2398–408.
10. Chapman M, Peake SL, Bellomo R, Davies A, Deane A, Horowitz M, et al. Energy-dense versus routine enteral nutrition in the critically ill. N Engl J Med. 2018;379(19):1823–34.
11. Harvey SE, Parrott F, Harrison DA, Bear DE, Segaran E, Beale R, et al. Trial of the route of early nutritional support in critically ill adults. N Engl J Med. 2014;371(18):1673–84.
12. Reignier J, Boisramé-Helms J, Brisard L, Lascarrou JB, Ait Hssain A, Anguel N, et al. Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2). Lancet. 2018;391(10116): 133–43.
13. Casaer MP, Wilmer A, Hermans G, Wouters PJ, Mesotten D, Van den Berghe G. Role of disease and macronutrient dose in the randomized controlled EPaNIC trial: a post hoc analysis. Am J Respir Crit Care Med. 2013;187(3):247–55.
92 C. Lauwers et al.
14. Vanhorebeek I, Verbruggen S, Casaer MP, Gunst J, Wouters PJ, Hanot J, et al. Effect of early supplemental parenteral nutrition in the paediatric ICU: a preplanned observational study of post-randomisation treatments in the PEPaNIC trial. Lancet Respir Med. 2017;5(6):475–83.
15. Casaer MP, Bellomo R. Micronutrient deciency in critical illness: an invisible foe? Intensive Care Med. 2019;45(8):1136–9.
16. Vankrunkelsven W, Gunst J, Amrein K, Bear DE, Berger MM, Christopher KB, et al. Moni­toring and parenteral administration of micronutrients, phosphate and magnesium in critically ill patients: the VITA-TRACE survey. Clin Nutr. 2020;40(2):590–9.
17. Doig GS, Simpson F, Heighes PT, Bellomo R, Chesher D, Caterson ID, et al. Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial. Lancet Respir Med. 2015;3(12):943–52.
18. Olthof LE, Koekkoek WACK, van Setten C, Kars JCN, van Blokland D, van Zanten ARH. Impact of caloric intake in critically ill patients with, and without, refeeding syndrome: a retrospective study. Clin Nutr. 2018;37(5):1609–17.
19. da Silva JSV, Seres DS, Sabino K, Adams SC, Berdahl GJ, Citty SW, et al. ASPEN consensus recommendations for refeeding syndrome. Nutr Clin Pract. 2020;35(2):178–95.
20. Adika E, Jia R, Li J, Seres D, Freedberg DE. Evaluation of the ASPEN guidelines for refeeding syndrome among hospitalized patients receiving enteral nutrition: a retrospective cohort study. JPEN J Parenter Enteral Nutr. 2022;46(8):1859–66.
21. Eveleens RD, Witjes BCM, Casaer MP, Vanhorebeek I, Guerra GG, Veldscholte K, et al. Supplementation of vitamins, trace elements and electrolytes in the PEPaNIC randomised controlled trial: composition and preparation of the prescription. Clin Nutr ESPEN. 2021;42: 244–51.
22. Hoffer LJ, Bistrian BR. Nutrition in critical illness: a current conundrum. F1000Res. 2016;5:
2531.
23. Felbinger TW, Weigand MA, Mayer K. Early or late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365(19):1839; author reply 41–2.
24. O’Leary MJ, Ferrie S. Early or late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365(19):1839–40; author reply 41–2.
25. Oshima T, Berger MM, De Waele E, Guttormsen AB, Heidegger CP, Hiesmayr M, et al. Indirect calorimetry in nutritional therapy. A position paper by the ICALIC study group. Clin Nutr. 2017;36(3):651–62.
26. Gunst J, Casaer MP, Preiser JC, Reignier J, van den Berghe G. Toward nutrition improving outcome of critically ill patients: how to interpret recent feeding RCTs? Crit Care. 2023;27(1):
43.
27. van Puffelen E, Hulst JM, Vanhorebeek I, Dulfer K, Van den Berghe G, Verbruggen S, et al. Outcomes of delaying parenteral nutrition for 1 week vs initiation within 24 hours among undernourished children in pediatric intensive care: a subanalysis of the PEPaNIC randomized clinical trial. JAMA Netw Open. 2018;1(5):e182668.
28. Arabi YM, Aldawood AS, Al-Dorzi HM, Tamim HM, Haddad SH, Jones G, et al. Permissive underfeeding or standard enteral feeding in high and low nutritional risk critically ill adults: post-hoc analysis of the PermiT trial. Am J Respir Crit Care Med. 2016;195(5):652–62.
29. Jensen GL, Cederholm T, Correia M, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community. JPEN J Parenter Enteral Nutr. 2019;43(1):32–40.
30. Heyland DK, Patel J, Compher C, Rice TW, Bear DE, Lee ZY, et al. The effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT protein): an international, multicentre, pragmatic, registry-based randomised trial. Lancet. 2023;401(10376):568–76. Doig GS,
31. amino acid therapy for kidney function in critically ill patients: a randomized controlled trial. Intensive Care Med. 2015;41(7):1197–208.
Simpson F, Bellomo R, Heighes PT, Sweetman EA, Chesher D, et al. Intravenous
8 The Energy Intake: How Much, and at What Time? 93
32. Singer P, Anbar R, Cohen J, Shapiro H, Shalita-Chesner M, Lev S, et al. The tight calorie control study (TICACOS): a prospective, randomized, controlled pilot study of nutritional support in critically ill patients. Intensive Care Med. 2011;37(4):601–9.
33. Singer P, De Waele E, Sanchez C, Ruiz Santana S, Montejo international: a multi-center, randomized, prospective controlled study comparing tight calorie control versus Liberal calorie administration study. Clin Nutr. 2021;40(2):380–7.
34. Casaer MP, Van den Berghe G, Gunst J. Indirect calorimetry: a faithful guide for nutrition therapy, or a fascinating research tool? Clin Nutr. 2021;40(2):651.
35. Chapple LS, Kouw IWK, Summers MJ, Weinel LM, Gluck S, Raith E, et al. Muscle protein synthesis after protein administration in critical illness. Am J Respir Crit Care Med. 2022;206 (6):740–9.
36. Hermans G, Casaer MP, Clerckx B, Guiza F, Vanhullebusch T, Derde S, et al. Effect of tolerating macronutrient decit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med. 2013;1(8):621–9.
37. Gunst J, Vanhorebeek I, Casaer MP, Hermans G, Wouters PJ, Dubois J, et al. Impact of early parenteral nutrition on metabolism and kidney injury. J Am Soc Nephrol. 2013;24(6): 995–1005.
38. Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368(16):1489–97.
39. Allingstrup MJ, Kondrup J, Wiis J, Claudius C, Pedersen UG, Hein-Rasmussen R, et al. Early goal-directed nutrition versus standard of care in adult intensive care patients: the single-centre, randomised, outcome assessor-blinded EAT-ICU trial. Intensive Care Med. 2017;43(11): 1637–47.
40. Tappy L, Schwarz JM, Schneiter P, Cayeux C, Revelly JP, Fagerquist CK, et al. Effects of isoenergetic glucose-based or lipid-based parenteral nutrition on glucose metabolism, de novo lipogenesis, and respiratory gas exchanges in critically ill patients. Crit Care Med. 1998;26(5): 860–7.
41. Gunst J, Casaer MP, Langouche L, Van den Berghe G. Role of ketones, ketogenic diets and intermittent fasting in ICU. Curr Opin Crit Care. 2021;27(4):385–9.
42. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4): 728–41.
43. Mizushima N, Levine B. Autophagy in human diseases. N Engl J Med. 2020;383(16):1564–76.
44. Gunst J. Recovery from critical illness-induced organ failure: the role of autophagy. Crit Care. 2017;21(1):209.
45. Derde S, Vanhorebeek I, Guiza F, Derese I, Gunst J, Fahrenkrog B, et al. Early parenteral nutrition evokes a phenotype of autophagy deciency in liver and skeletal muscle of critically ill rabbits. Endocrinology. 2012;153(5):2267–76.
46. De Bruyn A, Gunst J, Goossens C, Vander Perre S, Guerra GG, Verbruggen S, et al. Effect of withholding early parenteral nutrition in PICU on ketogenesis as potential mediator of its outcome benet. Crit Care. 2020;24(1):536.
47. De Bruyn A, Langouche L, Vander Perre S, Gunst J, Van den Berghe G. Impact of withholding early parenteral nutrition in adult critically ill patients on ketogenesis in relation to outcome. Crit Care. 2021;25(1):102.
48. Goossens C, Weckx R, Derde S, Dufour T, Vander Perre S, Pauwels L, et al. Adipose tissue protects against sepsis-induced muscle weakness in mice: from lipolysis to ketones. Crit Care. 2019;23(1):236.
49. Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38(1):48–79.
50. de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med. 2019;381(26):2541–51.
51.
Van Dyck fasting-mimicking diet for critically ill patients: the pilot randomized crossover ICU-FM-1 study. Crit Care. 2020;24(1):249.
L, Vanhorebeek I, Wilmer A, Schrijvers A, Derese I, Mebis L, et al. Towards a
JC, Laterre PF, et al. TICACOS
94 C. Lauwers et al.
52. Van Dyck L, Casaer MP. Intermittent or continuous feeding: any difference during the rst week? Curr Opin Crit Care. 2019;25(4):356–62.
53. McNelly AS, Bear DE, Connolly BA, Arbane G, Allum L, Tarbhai A, et al. Effect of intermittent or continuous feed on muscle wasting in critical illness: a phase 2 clinical trial. Chest. 2020;158(1):183–94.
54. Schuetz P, Fehr R, Baechli V, Geiser M, Deiss M, Gomes F, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet. 2019;393 (10188):2312–21.
55. Van Dyck L, Gunst J, Casaer MP, Peeters B, Derese I, Wouters PJ, et al. The clinical potential of GDF15 as a ready-to-feed indicatorfor critically ill adults. Crit Care. 2020;24(1):557.
56.
Berger MM, micronutrient guideline. Clin Nutr. 2022;41(6):1357–424.
Shenkin A, Schweinlin A, Amrein K, Augsburger M, Biesalski HK, et al. ESPEN
Chapter 9
Protein Requirements: Refocusing on an Essential Nutrient
Emmanuel Pardo and Jean-Charles Preiser

Introduction

The attention towards the long-term consequences of critical illness and a stay in an intensive care unit (ICU) has increased in recent years, coinciding with advance­ments in medical therapy that have led to an improved survival rate. Specically, muscle weakness acquired in the ICU is associated with a poor outcome [1, 2]. This
ion is characterized by qualitative and quantitative muscle alteration second-
condit ary to exacerbated catabolism [35]. Its consequences may persist over time and const
itute long-term functional and quality of life impairments [6, 7]. The introduc-
of early nutritional support has been advised by international guidelines to limit
tion energy and particularly protein debt in critically ill patients in order to potentially mitigate muscle loss [810]. However, the current level of evidence remains limited and
the risk-to-benet ratio of high protein intakes is unknown [11]. The prescription of protein intake should follow a careful timing and amount at each phase of the critical illness to avoid the development or further deterioration of adverse effects, including renal impairment.
Supplementary Information The online version contains supplementary material available at
https://doi.org/10.1007/978-3-031-66541-7_9.
E. Pardo Département dAnesthésie-Réanimation, Sorbonne Université, GRC 29, AP-HP, DMU DREAM, Hôpital Saint-Antoine, Assistance publique-hôpitaux de Paris, Paris, France e-mail: emmanuel.pardo@aphp.fr
J.-C. Preiser ( Erasme Hospital, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium e-mail: jean-charles.preiser@erasme.ulb.ac.be
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2024 A.
Cotoia et al. (eds.), Nutrition, Metabolism and Kidney Support,
https://doi.org/10.1007/978-3-031-66541-7_9
✉)
95